Cel-Sci adding more Multikine trial sites after recruitment slows
Cel-Sci says its CRO Ergomed has added more research sites to the Multikine Phase III study after patient enrolment slowed.
Cel-Sci says its CRO Ergomed has added more research sites to the Multikine Phase III study after patient enrolment slowed.
Wockhardt has received a GMP certificate from the UK’s MHRA for its facility in Chikalthana, India.
A new approval pathway could speed time-to-market for drugmakers developing antibiotics according to the US FDA.
Bridgepoint Capital has sold Quotient Clinical to GHO Capital, a fund backed by Quintiles founder Dennis Gillings.
An Israeli researcher says a cost-effective method for making human liver cells offers drug developers better safety evaluation and will “undoubtedly” replace animal testing.
A homebrew engineer is raising society and ethical questions after designing an at-home bioreactor for pharmaceutical drugs.